Successful treatment of humeral shaft nonunion with romosozumab: A case report

Romosozumab is a humanized monoclonal anti-sclerostin antibody (Scl-Ab) that binds and inhibits sclerostin, thereby increasing bone formation and decreasing bone resorption. In 2019, the Japanese Ministry of Health, Labor and Welfare, and the FDA approved romosozumab for treating osteoporosis in men...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Sang Yang, Kawasaki, Keikichi, Inagaki, Katsunori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718983/
https://www.ncbi.nlm.nih.gov/pubmed/35005169
http://dx.doi.org/10.1016/j.tcr.2021.100595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718983/
https://www.ncbi.nlm.nih.gov/pubmed/35005169
http://dx.doi.org/10.1016/j.tcr.2021.100595

Ejemplares similares